$ANKM
Ankam, Inc.

2023 Q2 Form 10-Q Financial Statement

#000178162923000010 Filed on April 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $10.60K $3.099K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.978K
YoY Change
% of Gross Profit
Operating Expenses $75.47K $84.78K
YoY Change 1053.68% 741.62%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $44.90K $44.90K
YoY Change
Pretax Income -$64.88K $81.68K
YoY Change -1091.68% 710.85%
Income Tax
% Of Pretax Income
Net Earnings -$64.88K -$81.68K
YoY Change 891.68% 710.85%
Net Earnings / Revenue -612.15% -2635.59%
Basic Earnings Per Share -$0.02 -$0.02
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 4.328M shares 4.328M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $3.956K $1.476K $2.277K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $10.00K
Receivables $4.800K
Other Receivables
Total Short-Term Assets $93.91K $126.3K $176.8K
YoY Change -42.91% 4169.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $255.2K $262.2K $269.2K
YoY Change 321.11% 3897.05%
TOTAL ASSETS
Total Short-Term Assets $93.91K $126.3K $176.8K
Total Long-Term Assets $255.2K $262.2K $269.2K
Total Assets $349.2K $388.6K $446.0K
YoY Change 55.1% 4000.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $541.9K $516.4K $492.2K
YoY Change 132.97% 1344.52%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $541.9K $516.4K $492.2K
Total Long-Term Liabilities
Total Liabilities $541.9K $516.4K $492.2K
YoY Change 132.97% 1344.52%
SHAREHOLDERS EQUITY
Retained Earnings $228.3K $163.4K $81.74K
YoY Change 430.16% 209.08%
Common Stock $4.328K $4.328K $4.328K
YoY Change 0.0% 33.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$192.7K -$127.8K -$46.15K
YoY Change
Total Liabilities & Shareholders Equity $349.2K $388.6K $446.0K
YoY Change 55.1% 4000.67%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$64.88K -$81.68K
YoY Change 891.68% 710.85%
Depreciation, Depletion And Amortization $6.978K
YoY Change
Cash From Operating Activities $85.50K
YoY Change 431.76%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $84.70K
YoY Change 141.84%
NET CHANGE
Cash From Operating Activities $85.50K
Cash From Investing Activities
Cash From Financing Activities $84.70K
Net Change In Cash -$801.00
YoY Change -104.23%
FREE CASH FLOW
Cash From Operating Activities $85.50K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001781629
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2022Q1 none Increase Decrease In Right Of Use Assets And Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLiabilitiesNet
usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
usd
CY2022Q1 us-gaap Interest Paid
InterestPaid
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-02-28
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-255392
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ANKAM INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1900749
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5348 Vegas Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89108
CY2023Q1 dei City Area Code
CityAreaCode
995
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
599420389
CY2023Q1 dei Contact Personnel Email Address
ContactPersonnelEmailAddress
[email protected]
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4327996 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1476 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2277 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4800 usd
CY2023Q1 us-gaap Assets Net
AssetsNet
124854 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
169752 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
126330 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
176829 usd
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
198710 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
198710 usd
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
63513 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
70491 usd
CY2023Q1 us-gaap Assets
Assets
388553 usd
CY2022Q4 us-gaap Assets
Assets
446030 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
85600 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
123499 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
6599 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
4000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
299717 usd
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
215017 usd
CY2023Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
124460 usd
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
149660 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
516376 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
492176 usd
CY2023Q1 us-gaap Liabilities
Liabilities
516376 usd
CY2022Q4 us-gaap Liabilities
Liabilities
492176 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4327996 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4327996 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4327996 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4327996 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
4328 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4328 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31262 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31262 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
163413 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
81736 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
127823 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46146 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
388553 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
446030 usd
CY2023Q1 us-gaap Revenues
Revenues
3099 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62981 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3012 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
14817 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
6500 usd
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
6978 usd
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
561 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
84776 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
10073 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
81677 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
10073 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
81677 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
10073 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4327996 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3222538 shares
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
3250000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-23195 usd
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
967000 shares
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
29010 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10073 usd
CY2022Q1 us-gaap Shares Outstanding
SharesOutstanding
4217000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4258 usd
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
4327996 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-46146 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-81677 usd
CY2023Q1 us-gaap Shares Outstanding
SharesOutstanding
4327996 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-127823 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
81677 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10073 usd
CY2023Q1 us-gaap Amortization And Depreciation Of Decontaminating And Decommissioning Assets
AmortizationAndDepreciationOfDecontaminatingAndDecommissioningAssets
6978 usd
CY2022Q1 us-gaap Amortization And Depreciation Of Decontaminating And Decommissioning Assets
AmortizationAndDepreciationOfDecontaminatingAndDecommissioningAssets
561 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4800 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6567 usd
CY2023Q1 none Increase Decrease In Right Of Use Assets And Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLiabilitiesNet
19698 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
37899 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2599 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
85501 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16079 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29010 usd
CY2023Q1 us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
84700 usd
CY2022Q1 us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
6013 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
84700 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35023 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-801 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18944 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2277 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
877 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1476 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19821 usd
CY2023Q1 us-gaap Revenue Recognition Allowances
RevenueRecognitionAllowances
<p id="xdx_842_eus-gaap--RevenueRecognitionAllowances_zr6cPVuCY3oh" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_86C_zd5oCSzY2oM">Revenue Recognition</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) No. 2014-09, <i>"Revenue from Contracts with Customer"</i>. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 1: Identify the contract with a customer</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 2: Identify the performance obligations in the contract</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 3: Determine the transaction price</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 4: Allocate the transaction price to the performance obligations in the contract</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zkXsWmYDhSDj" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_862_zqPBDSctdV2a">Use of Estimates</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1 none Server Agreement
ServerAgreement
124854 usd
CY2022Q4 none Server Agreement
ServerAgreement
169752 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
299717 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
215017 usd
CY2023Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
163413 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
81736 usd
CY2023Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-163413 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-81736 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
34317 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
17165 usd
CY2023Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
34317 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
17165 usd

Files In Submission

Name View Source Status
0001781629-23-000010-index-headers.html Edgar Link pending
0001781629-23-000010-index.html Edgar Link pending
0001781629-23-000010.txt Edgar Link pending
0001781629-23-000010-xbrl.zip Edgar Link pending
exh31.htm Edgar Link pending
exh32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q_28022023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20230228.xsd Edgar Link pending
none-20230228_pre.xml Edgar Link unprocessable
form10q_28022023_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
none-20230228_def.xml Edgar Link unprocessable
none-20230228_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
none-20230228_lab.xml Edgar Link unprocessable